Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/26/1998US5756348 DNA encoding a glycine transporter and uses thereof
05/26/1998US5756344 Polypeptide
05/26/1998US5756342 Monoclonal antibody or antigen binding fragment thereof, capable of blocking suppression of gamma-interferon
05/26/1998US5756330 Glycyl tRNA synthetase polynucleotides of streptococcus
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756323 Genetic engineering
05/26/1998US5756312 Dna molecule encoding polypeptide comprising two heterogeneous amino acid sequences from same variable domain of hepatitis c virus isolates
05/26/1998US5756310 Culture product
05/26/1998US5756309 Nucleic acid encoding a human G-protein receptor HPRAJ70 and method of producing the receptor
05/26/1998US5756300 Oligodendrocyte-specific protein and method for diagnosing and treating disease
05/26/1998US5756299 Human carbonyl reductase
05/26/1998US5756289 Protein kinases
05/26/1998US5756288 Cloning dna sequences for genes
05/26/1998US5756287 Complexing
05/26/1998US5756282 Oligonucleotides for the diagnosis of papillomavirus
05/26/1998US5756264 Expression vector systems and method of use
05/26/1998US5756097 Immunotherapeutic treatment of cancer
05/26/1998US5756096 Recombinant antibodies for human therapy
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/26/1998US5756094 Methods for stimulating follicular growth
05/26/1998US5756093 Polypeptides
05/26/1998US5756092 Use, in a composition, as cyclooxygenase activator and/or stabilizer, of at least one pyrimidine derivative sustituted at the 6th position and a cyclooxygenase substrate
05/26/1998US5756091 Method of treating tumour cells using catalase
05/26/1998US5756090 Oxygen activatable formulations for disinfection or sterilization
05/26/1998US5756086 Gene expression; anticarcinogenic agents
05/26/1998US5756085 Use of interleukin-12 to prevent graft versus host disease
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998US5756083 Mpl ligand analogs
05/26/1998US5756066 Contrast agent for x-ray diagnosis
05/26/1998US5755968 Dialysis system and method for removing toxic matter from the serum of the large intestine
05/26/1998CA2143322C Peptide diagnostics and therapeutics for spondyloarthropathies
05/26/1998CA2057053C Recombinant alzheimer's amyloid protein
05/25/1998CA2216622A1 Novel compounds
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021363A1 Compositions and methods for treating type ii diabetes involving hnf-4
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021350A1 Diminishing viral gene expression by promoter replacement
05/22/1998WO1998021348A1 Method of producing human growth factors from whole plants or plant cell cultures
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021344A1 Chimeric ltb vaccines
05/22/1998WO1998021343A1 Genes encoding telomerase proteins
05/22/1998WO1998021342A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
05/22/1998WO1998021337A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
05/22/1998WO1998021335A1 Chordin compositions
05/22/1998WO1998021334A2 Antibody mg1 recognizing a small subset of human hematopoietic cells
05/22/1998WO1998021333A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021330A1 Exodus chemokine materials and methods
05/22/1998WO1998021329A1 Novel human parotid secretory protein
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021325A1 Methods and reagents for preparing and using immunological agents specific for p-glycoprotein
05/22/1998WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998WO1998021323A2 Reversal of drug resistance through oligonucleotide complementary to plasmodium falciparum specific region
05/22/1998WO1998021320A2 TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
05/22/1998WO1998021318A1 Ubch7-like ubiquitin-conjugating enzyme
05/22/1998WO1998021314A2 Method of promoting b-cell proliferation and activation and of modulating the immune system
05/22/1998WO1998021243A1 Method and novel compounds for use therein
05/22/1998WO1998021242A1 Calcitonin receptor
05/22/1998WO1998021241A1 Human glutamate-binding protein
05/22/1998WO1998021240A1 Recombinant by55 and nucleic acids encoding same
05/22/1998WO1998021239A2 Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
05/22/1998WO1998021238A1 Recombinant single-stranded equine chorionic gonadotropin
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021236A1 Connective tissue growth factor-3
05/22/1998WO1998021235A1 Malarial binding site on duffy blood group protein
05/22/1998WO1998021233A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998WO1998021232A2 Mutant forms of fas ligand and uses thereof
05/22/1998WO1998021230A1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor
05/22/1998WO1998021229A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998WO1998021227A1 Mutant human hedgehog gene
05/22/1998WO1998021225A1 Helicobacter polypeptides and corresponding polynucleotide molecules
05/22/1998WO1998021193A1 Antithrombotic organic nitrates
05/22/1998WO1998020932A2 Conditioning for allogeneic stem cell transplantation
05/22/1998WO1998020907A1 TGFβ1-RESPONSIVE CELLS FROM BONE MARROW
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998WO1998020903A1 Humanized neutralizing antibodies against hemolytic uremic syndrome
05/22/1998WO1998020902A1 Peptide immunotherapeutic agent
05/22/1998WO1998020897A1 Modulation of map kinase phosphatase 1 (mkp-1)
05/22/1998WO1998020896A1 A method for inducing apoptosis of primary central nervous system b cell lymphomas
05/22/1998WO1998020895A1 Use of glp-1 peptides
05/22/1998WO1998020894A1 Regulation of neuroendocrine and reproductive function by administration of leptin
05/22/1998WO1998020893A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020892A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020891A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020890A1 Morphogen peptide-induced regeneration of sense perceptory tissues
05/22/1998WO1998020889A1 Morphogen peptide-induced regeneration of sense perceptory tissues
05/22/1998WO1998020888A1 Aids remedy
05/22/1998WO1998020887A1 Polyphosphoinositide binding peptides for intracellular drug delivery
05/22/1998WO1998020886A1 Pretraumatic use of hemoglobin
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020866A2 Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
05/22/1998WO1998020836A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/22/1998WO1998020803A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome
05/22/1998WO1998020736A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES
05/22/1998WO1998011221A3 CAR, a novel coxsackievirus and adenovirus receptor
05/22/1998WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same
05/22/1998WO1998001555A3 Truncated soluble tumor necrosis factor type-i and type-ii receptors
05/22/1998CA2308833A1 Malarial binding site on duffy blood group protein
1 ... 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 ... 3163